Keymed Biosciences Inc.
HKEX:2162.HK
37.85 (HKD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net Income
| -356.188 | -303.597 | -3,892.632 | -818.848 | -167.512 |
| Depreciation & Amortization
| 69.161 | 36.123 | 21.019 | 18.992 | 12.299 |
| Deferred Income Tax
| 0 | 0 | 56.145 | 0 | 0 |
| Stock Based Compensation
| 40.079 | 48.567 | 116.823 | 0 | 0 |
| Change In Working Capital
| 22.425 | -5.67 | 2.828 | -0.187 | -6.945 |
| Accounts Receivables
| -27.091 | 3.98 | -3.98 | 0 | 0 |
| Inventory
| -11.859 | -28.102 | -9.547 | -3.54 | -3.235 |
| Accounts Payables
| 0 | -3.98 | 3.98 | 0 | 0 |
| Other Working Capital
| 46.8 | 22.432 | 12.375 | 3.353 | -3.71 |
| Other Non Cash Items
| -71.516 | -177.357 | 3,481.18 | 680.682 | 93.779 |
| Operating Cash Flow
| -303.62 | -401.934 | -214.637 | -119.361 | -68.379 |
| Investing Activities: | |||||
| Investments In Property Plant And Equipment
| -382.61 | -279.549 | -172.858 | -19.896 | -62.302 |
| Acquisitions Net
| 0 | 0 | -21 | 4.621 | 0.038 |
| Purchases Of Investments
| -905.237 | -5,651.169 | -2,753.082 | -676.965 | -257 |
| Sales Maturities Of Investments
| 1,605.697 | 5,076.15 | 904.113 | 572.083 | 260.165 |
| Other Investing Activites
| 63.56 | 208.982 | 6.948 | 7.09 | 1.079 |
| Investing Cash Flow
| 468.203 | -645.586 | -2,035.879 | -113.067 | -58.02 |
| Financing Activities: | |||||
| Debt Repayment
| -287.355 | -14.518 | -12.905 | -5.614 | -5.673 |
| Common Stock Issued
| 0 | 0 | 2,887.641 | 0 | 0 |
| Common Stock Repurchased
| -32.901 | -51.135 | -58.154 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -153.187 | 57.594 | 834.699 | 13.011 | 510.739 |
| Financing Cash Flow
| 72.131 | -8.059 | 3,638.376 | 7.397 | 505.066 |
| Other Information: | |||||
| Effect Of Forex Changes On Cash
| 10.245 | 139.03 | -66.65 | -8.168 | 5.142 |
| Net Change In Cash
| 246.959 | -916.549 | 1,321.21 | -233.199 | 383.809 |
| Cash At End Of Period
| 851.029 | 604.07 | 1,520.619 | 199.409 | 432.608 |